Chinese Vaccine Approved for Human Testing

Image Title

Chinese Vaccine Approved for Human Testing


Reporterly Reporterly

18 Mar 2020

CanSino Biologics Inc said it received Chinese regulatory approval to start human trials of a vaccine against the novel coronavirus, another example of a potential weapon against the illness being fast-tracked for testing as the global death toll escalates and nations impose lockdowns on their citizens.

The vaccine, co-developed by the Hong Kong-listed company and China’s Academy of Military Medical Sciences, will undergo clinical trials in Wuhan, CanSino Biologics said in a statement to the Hong Kong Stock Exchange on Wednesday (March 18).

Wuhan is the epicentre for the pandemic that has spread to all corners of the planet, infecting more than 190,000 people and killing more than 7,800.